VORTIOXETINE

Vortioxetine is a multimodal antidepressant acting through serotonin reuptake inhibition and receptor modulation, improving mood and cognitive function. It benefits patients with major depressive disorder, especially those with cognitive symptoms. Side effects include nausea, dizziness, sexual dysfunction, insomnia, and rare risk of serotonin syndrome. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 0f5bef5e526a Category: Tag:

Product Description


Mechanism of Action

VORTIOXETINE exhibits a highdimensional biochemical interaction matrix spanning signallingaxis disruption, catalyticdomain modulation, mitochondrialnetwork recalibration, ionflux redistribution, cytoskeletalarchitecture remodelling, membranepotential rebalancing and transcriptionfactor pathway restructuring. Its molecular topology supports interaction with catalytic residues, allosteric regulators, transmembrane helices, nucleotidebinding pockets, redoxbuffer modules and polymeric scaffolding complexes, enabling wideband influence across metabolic, structural, genomic and electrophysiological domains.

Mechanistically, VORTIOXETINE may reshape phosphorylation maps across ERK/MAPK/JNK/p38 axes, alter PI3KAKT survivalbias, modulate Gprotein coupling geometry, redistribute Ca²⁺ microdomain waveforms, adjust IP/DAG signalling topology and recalibrate cAMPPKA amplitude. Mitochondrial impacts include ETCcomplex rebalancing, ATP/ADP cycle modulation, ROSthreshold displacement, mitochondrial membranepotential polarity shifts and crossorganelle stress signalling.

HighPrecision

  • Kinomescale interference & catalyticcascade modelling
  • Highresolution docking & conformationalflow prediction
  • UPR/ERstress & autophagy/mitophagy integration networks
  • Full multiomics reconstruction (RNAseq, proteomics, phosphoproteomics, metabolomics)
  • Cytoskeletal forcemapping & polymer turnover dynamics
  • Cellfate modelling: apoptosis, necroptosis, ferroptosis, parthanatos
  • AIdriven SAR/QSAR predictive simulation

Toxicodynamics & Cellular Hazard Spectrum

  • Excessive ROS accumulation & antioxidantbuffer collapse
  • Mitochondrial fragmentation or ETC suppression
  • Hyperdisruption of Na⁺/K⁺/Ca²⁺ ionicgradients
  • Cytoskeletal degradation & membrane-integrity failure
  • Inflammatory masterswitch activation (NF-κB/STAT/IRF)
  • Multiaxis programmed-cell-death induction
  • Epigenetic drift across methylation & acetylation layers

For expert laboratory research only not intended for biological use.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C18H22N2S

Molecular Weight

298.4 g/mol

CAS Number

508233-74-7

Storage Condition

Store at 77 °F (25 °C); excursions permitted to 59 °F to 86 °F (15 °C to 30 °C).

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

VORTIOXETINE; 508233-74-7; Lu AA21004; 1-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazine; vortioxetina

IUPAC/Chemical Name

1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine

InChl Key

YQNWZWMKLDQSAC-UHFFFAOYSA-N

InChl Code

InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/9966051;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download